KLOW Blend: Complete Research Peptide Overview (2026)
Everything researchers should know about the KLOW Blend multi-peptide formulation — components, in vitro research context, purity standards, and laboratory considerations.
Interest in multi-peptide research blends has grown significantly within laboratory and preclinical research communities. KLOW Blend is a four-component research peptide formulation comprising BPC-157, TB-500, KPV, and GHK-Cu — studied in experimental settings for its combined peptide structure and relevance to signalling complexity research in Canada.
Written by the NexPept Research Team · Last updated: July 2026
This page provides a complete educational overview of KLOW Blend for laboratory research purposes only. NexPept supplies KLOW Blend strictly for non-clinical, in vitro research applications, with an emphasis on purity, documentation, and batch consistency.
KLOW Blend is a multi-component research peptide formulation containing BPC-157 (15 AA), TB-500 (7 AA), KPV (3 AA), and GHK-Cu (3 AA + Cu²⁺). It is studied in laboratory settings for combined peptide signalling and molecular interaction research. The key factors that separate a trustworthy source from a questionable one are third-party testing (99%+ purity per component), batch-specific Certificates of Analysis, and reliable domestic Canadian shipping. This guide covers each in detail.
What Is KLOW Blend?
KLOW Blend is a formulated research peptide blend containing four distinct synthetic peptide components. Each component has its own structural characteristics, CAS number, and established in vitro research profile. In laboratory research settings, KLOW Blend is studied for how multiple peptides may interact within combined experimental frameworks — a model of multi-peptide signalling complexity.
As a blend of structurally diverse compounds — ranging from the 15-amino-acid BPC-157 to the short copper-binding tripeptide GHK-Cu — KLOW Blend is relevant to researchers examining how different peptide classes behave simultaneously within a controlled experimental environment.
KLOW Blend Component Reference
| Component | CAS Number | Chain Length | Compound Class | Primary Research Context |
|---|---|---|---|---|
| BPC-157 | 137525-51-0 | 15 amino acids | Synthetic linear peptide | Growth factor signalling, cellular research frameworks |
| TB-500 | 885340-08-9 | 7 amino acids | Synthetic peptide fragment | Actin-binding, cytoskeletal interaction studies |
| KPV | 69279-49-8 | 3 amino acids | Short-chain tripeptide (α-MSH fragment) | Melanocortin receptor interaction, peptide signalling |
| GHK-Cu | 89030-95-5 | 3 amino acids + Cu²⁺ | Copper-binding tripeptide | Peptide–metal ion interaction, cellular signalling models |
Because KLOW Blend is a proprietary multi-peptide formulation, no single CAS number or unified molecular formula applies to the preparation as a whole. Each component is analytically verified by HPLC and mass spectrometry prior to blending.
Why Researchers Study KLOW Blend
In laboratory and preclinical research environments, KLOW Blend has been investigated for its potential involvement in multi-peptide interaction research. The combination of structurally diverse peptides within a single lyophilized preparation allows researchers to examine concurrent signalling behaviour in controlled experimental systems — a model that is difficult to replicate using single-compound preparations alone.
Research applications include:
- Multi-peptide interaction research models
- Combined peptide signalling pathway studies
- Structure–function analysis involving peptide blends
- Experimental molecular and cellular research frameworks
- Concurrent receptor engagement studies in cell-based systems
All findings related to KLOW Blend remain limited to research and experimental contexts. Interpretations should be confined strictly to laboratory data and are not applicable to clinical or human-use settings. This compound is supplied for in vitro use only.
KLOW Blend Components: Individual Research Profiles
Understanding each component helps researchers evaluate KLOW Blend within appropriate in vitro research frameworks. Below is a brief overview of each peptide's established research context.
BPC-157 (Body Protection Compound-157)
BPC-157 (CAS 137525-51-0) is a 15-amino-acid synthetic pentadecapeptide extensively studied in experimental laboratory models. It has been examined in the context of growth factor signalling pathways, angiogenesis research, and cellular interaction frameworks. BPC-157 is one of the most widely researched peptides in Canada and internationally within preclinical settings.
TB-500 (Thymosin Beta-4 Fragment 17–23)
TB-500 (CAS 885340-08-9) is a synthetic 7-amino-acid fragment of thymosin beta-4. It has been studied for its role in actin-binding interactions and cytoskeletal research models, where it is explored in the context of structural peptide biology and cellular motility studies in vitro.
KPV (Lysine-Proline-Valine)
KPV (CAS 69279-49-8) is a short-chain tripeptide corresponding to the C-terminal region of alpha-melanocyte-stimulating hormone (α-MSH). It has been examined in melanocortin receptor interaction studies and peptide signalling research, where short-chain peptide fragments are studied for their molecular interaction properties in controlled laboratory environments.
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper II)
GHK-Cu (CAS 89030-95-5) is a naturally occurring copper-binding tripeptide found endogenously in human plasma. It has been studied extensively in cellular signalling research and peptide–metal ion interaction models, with a well-established preclinical literature base examining its behaviour in skin biology and wound-related cellular research.
Purity & Documentation for KLOW Blend Research
High peptide purity is critical for reproducible in vitro research outcomes. Variations in synthesis quality or incomplete documentation can introduce inconsistencies into experimental data — particularly in multi-component formulations where cross-component contamination is a compounding risk.
When evaluating a KLOW Blend supplier in Canada, researchers should look for:
- Third-party analytical testing — HPLC and mass spectrometry performed on each component independently
- Batch-specific identification — each vial traceable to a documented production lot with its own COA
- Verified purity percentages per component — ≥99% purity is the accepted research benchmark
- Certificates of Analysis (COAs) issued by an independent laboratory, not the supplier's in-house team
- Transparent documentation — COAs that can be verified directly with the issuing lab upon request
NexPept provides third-party COAs for every batch. Researchers can view COAs here or contact us to verify any batch directly with the testing laboratory.
Storage & Handling (Research Use Only)
Proper storage and handling are essential to preserving the integrity of KLOW Blend in laboratory settings. As a multi-component lyophilized formulation, handling conditions should be established by qualified research personnel with reference to the most stability-sensitive component's requirements.
General laboratory storage considerations include:
- Store sealed lyophilized material under controlled laboratory conditions in accordance with validated institutional SOPs
- Protect from moisture and prolonged light exposure at all times
- Adhere to institution-approved handling and storage protocols
- Follow your laboratory's established procedures for lyophilized multi-component preparations
No preparation, reconstitution, or administration instructions are provided or implied. KLOW Blend is supplied for in vitro laboratory research use only. All handling must be conducted by qualified personnel following institutional safety protocols.
Sourcing KLOW Blend Research Peptides in Canada
When sourcing KLOW Blend or any multi-peptide research formulation in Canada, researchers typically prioritize consistent quality, transparent documentation, and reliable domestic shipping. Domestic Canadian sourcing offers faster turnaround, eliminates customs delays, and reduces temperature-chain risks associated with cross-border international shipping.
Key factors to evaluate when choosing a Canadian KLOW Blend supplier:
- Independent third-party testing with verifiable COAs for each component
- Clear research-use-only labeling on all products
- Batch-specific documentation and lot traceability
- Transparent product descriptions with component-level purity data
- Reliable Canadian shipping with tracking through Canada Post or FedEx
Related Research Peptides Available in Canada
Researchers exploring KLOW Blend may also be interested in the individual component overviews and related Canadian research peptide resources. Each component in the KLOW formulation has an independent research literature base that can provide additional context for multi-component blend studies.
- BPC-157 Research Peptide Overview — detailed profile of the 15 AA pentadecapeptide component
- TB-500 Research Peptide Overview — structural and actin-binding research context
- GHK-Cu Research Peptide Overview — copper-binding tripeptide research profile
- Buy Peptides Canada — full catalogue of lab-tested research peptides available in Canada
- Research Peptides in Canada — sourcing, regulation, and quality guidance for Canadian researchers
- What Are Research Peptides? — classification and in vitro research context
Common Questions About KLOW Blend
What is KLOW Blend?
KLOW Blend is a multi-component research peptide formulation containing four distinct peptides: BPC-157 (15 AA), TB-500 (7 AA), KPV (3 AA), and GHK-Cu (3 AA + Cu²⁺). It is supplied as a lyophilized powder for in vitro laboratory research use only and is not authorized for human or veterinary use.
What does KLOW Blend contain?
KLOW Blend contains BPC-157 (CAS 137525-51-0), TB-500 / Thymosin Beta-4 fragment (CAS 885340-08-9), KPV / Lysine-Proline-Valine (CAS 69279-49-8), and GHK-Cu / Glycyl-L-Histidyl-L-Lysine Copper II (CAS 89030-95-5). Each component is independently verified by HPLC and mass spectrometry prior to formulation.
Is KLOW Blend available in Canada?
Yes. NexPept supplies KLOW Blend (80 mg / vial) from within Canada, with domestic shipping via Canada Post and FedEx. Each batch is third-party tested to ≥99% purity per component, with batch-specific Certificates of Analysis available upon request.
How should KLOW Blend be stored in a laboratory setting?
Store sealed lyophilized material under controlled laboratory conditions in accordance with your institution's validated SOPs. Protect from moisture and light. As a multi-component formulation, storage conditions should be established by qualified research personnel with reference to the most stability-sensitive component. No reconstitution or administration instructions are provided.
Does KLOW Blend have a single CAS number?
No. As a proprietary multi-component blend of four chemically distinct peptides, KLOW Blend does not have a single unified CAS number. Each component has its own CAS: BPC-157 (137525-51-0), TB-500 (885340-08-9), KPV (69279-49-8), GHK-Cu (89030-95-5).
Why choose a Canadian supplier for KLOW Blend?
Domestic Canadian sourcing eliminates customs delays and international shipping risks, ensures faster tracked delivery (typically 1–5 business days nationwide), and reduces temperature-chain uncertainty for sensitive lyophilized formulations. NexPept ships from within Canada with full batch documentation.
Is KLOW Blend approved for human use?
No. KLOW Blend is not authorized by Health Canada for human or veterinary use. It is supplied exclusively for in vitro laboratory and non-clinical research use by qualified research personnel. No therapeutic, clinical, or health claims are made.
KLOW Blend Research Peptide: Key Points
- KLOW Blend is a four-component research peptide formulation (BPC-157, TB-500, KPV, GHK-Cu)
- Studied in vitro for multi-peptide interaction and combined signalling pathway research
- Supplied as lyophilized powder — 80 mg per vial
- Each component independently verified to ≥99% purity by HPLC and mass spectrometry
- Batch-specific COAs available; no single CAS number applies to the blend as a whole
- Not authorized by Health Canada for human or veterinary use
- Available domestically in Canada with tracked shipping nationwide
Source Verified KLOW Blend Research Peptides in Canada
Every batch is third-party tested to 99%+ purity per component, batch-tracked with individual COAs, and shipped fast within Canada.
View KLOW Blend Research Product →This guide is intended to provide a foundational understanding of KLOW Blend as a multi-component research peptide formulation. Whether you are evaluating suppliers, reviewing component research profiles, or seeking documentation standards for your laboratory, accurate information supports better research decisions when sourcing research peptides in Canada.